论文信息 - Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma. - 字舞流文

Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.

I. Jurisica | B. Neel | M. Tsao | Ni Liu | F. Shepherd | T. John | Geoffrey Liu | N. Pham | C. Mascaux | M. Pintilie | Chang-Qi Zhu | T. Waddell | S. Sakashita | J. Sykes | N. Leighl | L. Kim | Petra Martin | E. Stewart | Ming Li | N. Yanagawa | Dennis Wang | C. Ng | Kota Ishizawa | Ghassan Allo